| Literature DB >> 33571527 |
Samantha J Wong1, Alison E Ringel1, William Yuan2, Joao A Paulo1, Haejin Yoon1, Mark A Currie3, Marcia C Haigis4.
Abstract
Since the discovery of the prolyl hydroxylases domain (PHD) proteins and their canonical hypoxia-inducible factor (HIF) substrate two decades ago, a number of in vitro hydroxylation (IVH) assays for PHD activity have been developed to measure the PHD-HIF interaction. However, most of these assays either require complex proteomics mass spectrometry methods that rely on the specific PHD-HIF interaction or require the handling of radioactive material, as seen in the most commonly used assay measuring [14C]O2 release from labeled [14C]α-ketoglutarate. Here, we report an alternative rapid, cost-effective assay in which the consumption of α-ketoglutarate is monitored by its derivatization with 2,4-dinitrophenylhydrazine (2,4-DNPH) followed by treatment with concentrated base. We extensively optimized this 2,4-DNPH α-ketoglutarate assay to maximize the signal-to-noise ratio and demonstrated that it is robust enough to obtain kinetic parameters of the well-characterized PHD2 isoform comparable with those in published literature. We further showed that it is also sensitive enough to detect and measure the IC50 values of pan-PHD inhibitors and several PHD2 inhibitors in clinical trials for chronic kidney disease (CKD)-induced anemia. Given the efficiency of this assay coupled with its multiwell format, the 2,4-DNPH α-KG assay may be adaptable to explore non-HIF substrates of PHDs and potentially to high-throughput assays.Entities:
Keywords: 2,4-dinitrophenylhydrazine; enzyme kinetics; high-throughput assay; in vitro hydroxylation; prolyl hydroxylase; α-ketoglutarate-dependent dioxygenases
Mesh:
Substances:
Year: 2021 PMID: 33571527 PMCID: PMC7961094 DOI: 10.1016/j.jbc.2021.100397
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157